BCL2 and cancer: Cancer driver gene expression was characterised by the expression of the DNA damage inducible transcript 3 (DDIT3), the mTOR kinase gene FRAP1, the anti-apoptotic gene BCL2 and several autophagy-related genes of the ATG and SEC family, and downregulation of the TP53 gene among others (Fig. 5c).